Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00298337
Previous Study | Return to List | Next Study

Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00298337
Recruitment Status : Unknown
Verified March 2006 by University of Helsinki.
Recruitment status was:  Active, not recruiting
First Posted : March 2, 2006
Last Update Posted : October 18, 2006
Sponsor:
Information provided by:
University of Helsinki

Tracking Information
First Submitted Date  ICMJE March 1, 2006
First Posted Date  ICMJE March 2, 2006
Last Update Posted Date October 18, 2006
Study Start Date  ICMJE October 1999
Primary Completion Date Not Provided
Current Primary Outcome Measures  ICMJE Not Provided
Original Primary Outcome Measures  ICMJE Not Provided
Change History
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
Official Title  ICMJE Not Provided
Brief Summary The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Phase 2
Phase 3
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Prevention
Condition  ICMJE
  • Atopic Dermatitis
  • Food Hypersensitivity
  • Allergic Rhinitis, Seasonal
  • Allergic Conjunctivitis
  • Asthma
Intervention  ICMJE Drug: Mixture of probiotic bacteria and prebiotic oligosaccharide
Study Arms  ICMJE Not Provided
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Unknown status
Enrollment  ICMJE Not Provided
Original Enrollment  ICMJE Not Provided
Study Completion Date  ICMJE December 2007
Primary Completion Date Not Provided
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • mother or father fo child with doctor diagnoses allergic disease

Exclusion Criteria:

  • prematurity, major malformations
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 37 Weeks to 42 Weeks   (Child)
Accepts Healthy Volunteers  ICMJE Not Provided
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Finland
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT00298337
Other Study ID Numbers  ICMJE T101060058;T1040A0002;T110612
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Not Provided
Study Sponsor  ICMJE University of Helsinki
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Study Chair: Erkki Savilahti, Professor Helsinki University Central Hospital, Hospital for Children and Adults, PO Box 281, 00029 HUS, Finland
PRS Account University of Helsinki
Verification Date March 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP